Access to care in rare liver diseases: New challenges and new opportunities
Standard
Access to care in rare liver diseases: New challenges and new opportunities. / Jones, David E J; Sturm, Ekkehard; Lohse, Ansgar W.
In: J HEPATOL, Vol. 68, No. 3, 03.2018, p. 577-585.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Access to care in rare liver diseases: New challenges and new opportunities
AU - Jones, David E J
AU - Sturm, Ekkehard
AU - Lohse, Ansgar W
N1 - Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
PY - 2018/3
Y1 - 2018/3
N2 - Patients with rare diseases are often disadvantaged, particularly those with rare liver diseases. Reasons for disadvantage include delayed or overlooked diagnosis, lack of local expertise and high-quality care, poor scientific understanding of the disease process and limited therapeutic options. In adult liver disease this can be compounded by prejudices towards patients with liver disease in general, because of a perception (incorrect for all rare liver diseases) that liver disease is lifestyle related and thus "self-inflicted". In paediatric rare liver diseases, such as biliary atresia, optimising outcomes requires a particularly timely diagnosis. Irrespective of patient age, the scientific and medical community must rise to the challenge of advancing our understanding of rare liver disease, searching for more effective and specific therapies, and providing the infrastructure to provide the best care for all patients, infants, children, young and older adults. The European Reference Network for Rare Liver Diseases is an important step in this direction.
AB - Patients with rare diseases are often disadvantaged, particularly those with rare liver diseases. Reasons for disadvantage include delayed or overlooked diagnosis, lack of local expertise and high-quality care, poor scientific understanding of the disease process and limited therapeutic options. In adult liver disease this can be compounded by prejudices towards patients with liver disease in general, because of a perception (incorrect for all rare liver diseases) that liver disease is lifestyle related and thus "self-inflicted". In paediatric rare liver diseases, such as biliary atresia, optimising outcomes requires a particularly timely diagnosis. Irrespective of patient age, the scientific and medical community must rise to the challenge of advancing our understanding of rare liver disease, searching for more effective and specific therapies, and providing the infrastructure to provide the best care for all patients, infants, children, young and older adults. The European Reference Network for Rare Liver Diseases is an important step in this direction.
KW - Journal Article
KW - Review
U2 - 10.1016/j.jhep.2017.11.004
DO - 10.1016/j.jhep.2017.11.004
M3 - SCORING: Review article
C2 - 29113911
VL - 68
SP - 577
EP - 585
JO - J HEPATOL
JF - J HEPATOL
SN - 0168-8278
IS - 3
ER -